Recombinant Human Thyroid Stimulating Hormone

DRUG2 trials

Sponsors

Nanjing First Hospital, Nanjing Medical University

Conditions

DTC - Differentiated Thyroid CancerRadiotherapy; ComplicationsRecombinant Human Thyroid Stimulating HormoneThyroid Stimulating; Hormone, C

Unknown Phase

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

RecruitingNCT06405217

Nanjing First Hospital, Nanjing Medical UniversityDTC - Differentiated Thyroid Cancer, Radiotherapy; Complications, Thyroid Stimulating; Hormone, C

Start: 2024-04-20End: 2026-12-31Target: 30Updated: 2024-05-08

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

RecruitingNCT06431620

Nanjing First Hospital, Nanjing Medical UniversityRecombinant Human Thyroid Stimulating Hormone

Start: 2024-06-30End: 2026-12-31Target: 15Updated: 2024-05-28